Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1084

1.

The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer's disease: an overview of pre-clinical studies and translational perspectives in clinical practice.

Cascella M, Bimonte S, Muzio MR, Schiavone V, Cuomo A.

Infect Agent Cancer. 2017 Jun 19;12:36. doi: 10.1186/s13027-017-0145-6. eCollection 2017. Review.

2.

Effect of suppressive acyclovir administered to HSV-2 positive mothers from week 28 to 36 weeks of pregnancy on adverse obstetric outcomes: a double-blind randomised placebo-controlled trial.

Nakubulwa S, Kaye DK, Bwanga F, Tumwesigye NM, Nakku-Joloba E, Mirembe F.

Reprod Health. 2017 Mar 3;14(1):31. doi: 10.1186/s12978-017-0292-7.

3.

Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids.

Kesharwani A, Polachira SK, Nair R, Agarwal A, Mishra NN, Gupta SK.

BMC Complement Altern Med. 2017 Feb 14;17(1):110. doi: 10.1186/s12906-017-1620-8.

4.

BX-795 inhibits HSV-1 and HSV-2 replication by blocking the JNK/p38 pathways without interfering with PDK1 activity in host cells.

Su AR, Qiu M, Li YL, Xu WT, Song SW, Wang XH, Song HY, Zheng N, Wu ZW.

Acta Pharmacol Sin. 2017 Mar;38(3):402-414. doi: 10.1038/aps.2016.160. Epub 2017 Jan 23.

5.

An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs.

Awasthi S, Hook LM, Shaw CE, Pahar B, Stagray JA, Liu D, Veazey RS, Friedman HM.

PLoS Pathog. 2017 Jan 19;13(1):e1006141. doi: 10.1371/journal.ppat.1006141. eCollection 2017 Jan.

6.

Commercial sex and risk of HIV, syphilis, and herpes simplex virus-2 among men who have sex with men in six Chinese cities.

Zheng C, Xu JJ, Hu QH, Yu YQ, Chu ZX, Zhang J, Han XX, Lu L, Wang Z, Fu JH, Chen X, Yan HJ, Jiang YJ, Geng WQ, Vermund SH, Qian HZ, Shang H.

BMC Infect Dis. 2016 Dec 21;16(1):765. doi: 10.1186/s12879-016-2130-x.

8.

HLA Class I and II alleles, heterozygosity and HLA-KIR interactions are associated with rates of genital HSV shedding and lesions.

Magaret A, Dong L, John M, Mallal SA, James I, Warren T, Gaudieri S, Koelle DM, Wald A.

Genes Immun. 2016 Dec;17(7):412-418. doi: 10.1038/gene.2016.42. Epub 2016 Nov 17.

9.

School-based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents.

Mason-Jones AJ, Sinclair D, Mathews C, Kagee A, Hillman A, Lombard C.

Cochrane Database Syst Rev. 2016 Nov 8;11:CD006417. Review.

10.

Seroprevalence and correlates of herpes simplex virus type 2 infection among young adults in Arkhangelsk, Northwest Russia: a population-based cross-sectional study.

Balaeva T, Grjibovski AM, Sidorenkov O, Samodova O, Firsova N, Sannikov A, Klouman E.

BMC Infect Dis. 2016 Oct 28;16(1):616.

11.

An Epigenetic Compound Library Screen Identifies BET Inhibitors That Promote HSV-1 and -2 Replication by Bridging P-TEFb to Viral Gene Promoters through BRD4.

Ren K, Zhang W, Chen X, Ma Y, Dai Y, Fan Y, Hou Y, Tan RX, Li E.

PLoS Pathog. 2016 Oct 20;12(10):e1005950. doi: 10.1371/journal.ppat.1005950. eCollection 2016 Oct.

12.

HSV-2 glycoprotein gD targets the CC domain of tetherin and promotes tetherin degradation via lysosomal pathway.

Liu Y, Li M, Zhang D, Zhang M, Hu Q.

Virol J. 2016 Sep 15;13(1):154. doi: 10.1186/s12985-016-0610-7.

13.

B Virus (Macacine Herpesvirus 1) Divergence: Variations in Glycoprotein D from Clinical and Laboratory Isolates Diversify Virus Entry Strategies.

Patrusheva I, Perelygina L, Torshin I, LeCher J, Hilliard J.

J Virol. 2016 Sep 29;90(20):9420-32. doi: 10.1128/JVI.00799-16. Print 2016 Oct 15.

14.

Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period.

Woestenberg PJ, Tjhie JH, de Melker HE, van der Klis FR, van Bergen JE, van der Sande MA, van Benthem BH.

BMC Infect Dis. 2016 Aug 2;16:364. doi: 10.1186/s12879-016-1707-8.

15.

Incidence of and temporal relationships between HIV, herpes simplex II virus, and syphilis among men who have sex with men in Bangkok, Thailand: an observational cohort.

Thienkrua W, Todd CS, Chonwattana W, Wimonsate W, Chaikummao S, Varangrat A, Chitwarakorn A, van Griensven F, Holtz TH.

BMC Infect Dis. 2016 Jul 22;16:340. doi: 10.1186/s12879-016-1667-z.

16.

Oral treatment with valacyclovir for HSV-2-associated eczema herpeticum in a 9-month-old infant: A case report.

Zhuang K, Wu Q, Ran X, Ran Y, Ding L, Xu X, Lei S, Lama J.

Medicine (Baltimore). 2016 Jul;95(29):e4284. doi: 10.1097/MD.0000000000004284.

17.

Herpes Simplex Virus 2 Virion Host Shutoff Endoribonuclease Activity Is Required To Disrupt Stress Granule Formation.

Finnen RL, Zhu M, Li J, Romo D, Banfield BW.

J Virol. 2016 Aug 12;90(17):7943-55. doi: 10.1128/JVI.00947-16. Print 2016 Sep 1.

18.

Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital Mucosa.

Schiffer JT, Swan DA, Magaret A, Schacker TW, Wald A, Corey L.

PLoS One. 2016 Jun 10;11(6):e0155124. doi: 10.1371/journal.pone.0155124. eCollection 2016.

19.

Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action.

Ceña-Diez R, Vacas-Córdoba E, García-Broncano P, de la Mata FJ, Gómez R, Maly M, Muñoz-Fernández MÁ.

Int J Nanomedicine. 2016 May 19;11:2147-62. doi: 10.2147/IJN.S95301. eCollection 2016.

20.

Exocytosis of Alphaherpesvirus Virions, Light Particles, and Glycoproteins Uses Constitutive Secretory Mechanisms.

Hogue IB, Scherer J, Enquist LW.

MBio. 2016 Jun 7;7(3). pii: e00820-16. doi: 10.1128/mBio.00820-16.

Supplemental Content

Loading ...
Support Center